Arresting Vertical Transmission of Hepatitis B Virus in the Democratic Republic of the Congo: The AVERT-HBV Study
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 26 Nov 2019
Price : $35 *
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary) ; Hepatitis B vaccine recombinant
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms AVERT-HBV
- 22 Nov 2019 Status changed from recruiting to active, no longer recruiting.
- 11 Oct 2018 Status changed from not yet recruiting to recruiting.
- 28 Jun 2018 New trial record